Doctors get good and bad safety news on diabetes drugs (Reuters, 2 September 2013)

03 Sept 2013


Data on cardiovascular outcomes with trials of two DPP-4 inhibitors are presented at the European Society of Cardiology annual congress in Amsterdam and published in the New England Journal of Medicine.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story